Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for MIFEPRISTONE
- A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- To Prevent Type I-II Myoma After TCRM Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or Mifepristone
- Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location
- Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)
- Atorvastatin as a Potential Adjunct to Misoprostol for Termination of Pregnancy
- The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy
- Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial
- Comparison Between Letrozole and Mifepristone in Medical Termination of First Trimester Miscarriages
- RESET-medication Glucocorticoid Receptor (GR) Blockade as Disease Modifying Treatment for Depression With Childhood Trauma
- Ulipristal Acetate for Use in Early Pregnancy Loss
- Mifepristone Outpatient Labour Induction
- Long-term Use of Mifepristone in the Treatment of Adenomyosis
- Comparison of Two Different Drug Regimens for Medical Treatment of Early Pregnancy Loss
- Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks
- Mifepristone for Labor Induction
- Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.
- Methadone and Medication Abortion
- Amniotomy for Second-trimester Pregnancy Termination
- The HYsteroscopic Miscarriage MaNagement Trial: A Pilot RCT Investigating a Novel Management Pathway for RPOC
- Management of RPOC After Induced Abortion
- Assessing Use Of Mifepristone After Progestin Priming For Use As "Missed Period Pills"
- Mifepristone Dynamic Testing for Diagnosis for Central Adrenal Insufficiency
- Improving Access to Abortion in the Republic of Georgia
- Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD)
- Letrozole in Tubal Ectopic Pregnancy
- Understanding GWI: Integrative Modeling
- TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis Reset
- Effectiveness of Pretreatment Letrozole Versus Misoprostol Alone in Missed Abortion
- Pilot Study of an Ambulatory Medical Abortion Service at 13-18 Weeks of Gestation in Colombia
- Treatment of Prolonged Uterine Bleeding of Etonogestrel (ENG)-Releasing Implant
- Assessing Medical Menstrual Regulation in the United States
- Mail Order Mifepristone Study
- Advance Provision of Medication Abortion
- Ulipristal Acetate for Cervical Preparation
- Blocking Mifepristone Action With Progesterone
- Cervical Preparation With Mifepristone Prior to Osmotic Dilators
- Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
- Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis
- CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)
- Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion
- Comparison of the Effectiveness of Treatment With Mifepristone and Misoprostol at the Same Time Compared to the Administration of Drugs at a 48-hour Interval for Medical Abortion.
- Outpatient Service for Mid-trimester Termination of Pregnancy
- Medication Abortion Via Pharmacy Dispensing
- Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina Faso
- Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor
- Crossover Drug-Drug Interaction Study to Determine Effects of Cytochrome P450 3A on Exposure to Mifepristone and Its Metabolites
- Glucocorticoid Antagonist Treatment for Tobacco Use Disorder
- Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer
- Comparing Two Medical Treatments for Early Pregnancy Failure.
- A Study on the Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and Efficacy
- 24-hour Mifepristone and Buccal Versus Mifepristone and Vaginal Misoprostol for Cervical Preparation for D&E
- Intervention to End Recurrent Unscheduled Bleeding Trial
- Mifepristone and Misoprostol Versus Misoprostol Alone in the Medical Management of Missed Miscarriage
- Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus
- Cervical Preparation of Abortions Under Paracervical Block in the First Trimester:
- S9005 Mifepristone in Meningioma
- INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers
- Acceptability and Feasibility of Medical Abortion in Singapore
- Acceptability and Feasibility of a Simplified Medical Abortion Service Delivery in Western Ukraine
- Misoprostol 400 µg Versus 200 µg for Cervical Ripening in 1st Trimester Miscarriage
- Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer
- Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks
- A Pilot of an Outpatient Regimen of Medical Abortion With Mifepristone and Sublingual Misoprostol in the 11 and 12 Weeks
- A Comparison of Sublingual and Buccal Misoprostol Regimens After Mifepristone for Mid-trimester Abortion
- Non-surgical Alternatives to Treatment of Failed Medical Abortion
- Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks
- Pain and Medical Abortion Among Teenaged Women Compared to Adult Women
- Mifepristone for Breast Cancer Patients With Higher Levels of Progesterone Receptor Isoform A Than Isoform B.
- Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
- Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal Death
- Mifepristone Induction for Fetal Demise
- IVF Outcome Following Treatment With Ulipristal Acetate for Myomatous Uterus After at Least One IVF Failure
- Ulipristal Acetate In Disease Charcot-Marie-Tooth Type of 1A
- Same-Day Mifepristone-Misoprostol Compared to Misoprostol Only for Surgical Abortion Cervical Preparation
- Acceptability and Feasibility of a Simplified Medical Abortion Regimen in Georgia
- Short-Term Oral Mifepristone for Central Serous Chorioretinopathy
- Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled Trial
- Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation
- Mifepristone 2.5, 5, 10 mg Versus Placebo in the Treatment of Endometriosis
- Mifepristone for the Prevention of Relapses of Alcohol Drinking
- Acceptability and Feasibility of a Demedicalized Medical Abortion Regimen in the Caucasus
- Mifepristone Treatment of Alcohol Use Disorder
- Medication Enhanced Rapid Therapy
- Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
- Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushing Syndrome
- Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days' Gestation in Kazakhstan
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors
- Comparative Effectiveness of Pregnancy Failure Management Regimens
- Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
- Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism
- Effects of Mifepristone on Biomarkers of Metabolic Function and Neuropsychological Performance Among Middle-Aged and Older Individuals
- Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone
- Pretreatment With Mifepristone Prior to Mirena Insertion
- Mifepristone in Children With Refractory Cushing's Disease
- Quickstart of Nexplanon® at Medical Abortion
- BRCA1/2 and Effect of Mifepristone on the Breast
- Pre-Operative Effects of Mifepristone on Dilation and Evacuation Services
- Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days Gestation
- Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion
- Introducing Mifepristone-Misoprostol for Menstrual Regulation in Public Sector Facilities in Bangladesh
- Cervical Preparation for Surgical Abortion at 12-14 Weeks: a Prospective, Randomized, Evaluator-blinded, Multicenter, Controlled Comparison Between Mifepristone, Misoprostol and Their Combination
- Mifepristone to Treat Uterine Fibroids
- Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks)
- Cervical Preparation Before Dilation and Evacuation
- Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone
- Mifepristone Versus Misoprostol for Cervical Preparation Prior to Surgical Abortion Between 11 to 15 Weeks
- Pilot Study of Pharmaceutical and Behavioral Interventions to Treat Anxiety Disorders
- Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks
- Medication Development in Alcoholism: Investigating Glucocorticoid Antagonists
- Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer
- Developing Memory Reconsolidation Blockers as Novel Posttraumatic Stress Disorder (PTSD) Treatments
- Study on Combined Use of Letrozole, Mifepristone and Misoprostol in Termination of Pregnancy
- Pain Control In First Trimester Medical Abortion: A Randomized Trial
- Mifepristone Versus Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks
- Mifepristone Effects on Glucose Intolerance in Obese/Overweight Adults
- Comparing Two Regimens for Medical Abortion: Mifepristone + Misoprostol Versus Misoprostol Alone
- Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
- Same-day Long-acting Reversible Contraception for Medication Abortion
- Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders
- Evaluation of Cortisol Resistance in Young Sedentary and Endurance-Trained Men
- The Effect of Mifepristone on the Expression of Cervical Prostaglandin EP3 Receptors
- Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
- Preoperative Misoprostol in Reducing Blood Loss in Total Abdominal Hysterectomy (TAH)
- Expansion Study of a Simplified Regimen of Medical Abortion Thru 63 Last Menstrual Period (LMP) in Tunisia
- A Prospective Randomized Comparison Trial on the Use of Mifepristone With Sublingual or Buccal Misoprostol for Medical Abortions of Less Than 9 Weeks Gestation
- Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer
- Investigation of Mifepristone (RU486) on Stress Sensitivity and Relapse Prevention in Cocaine Dependent Patients
- The Extended Gestational Age Medical Abortion Study
- Efficacy Study of Prophylactic Ibuprofen Versus Placebo on Pain Relief and Success Rates of Medical Abortion
- Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion
- Mifepristone Versus Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks
- Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))
- Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14-21 Weeks LMP)
- Misoprostol for Second Trimester Termination of Pregnancy
- An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
- Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids
- Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids
- Study of 400mcg Sublingual Versus 400mcg Buccal Misoprostol Following 200mg Mifepristone for Medical Abortion up to 63 Days Last Menstrual Period (LMP)
- Treatment of Psychotic Major Depression With Mifepristone
- Techniques to Improve Efficacy of Second Trimester Medical Termination
- Trial of Mifepristone in Combat Veterans With Posttraumatic Stress Disorder
- Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers
- Misopristol Versus Pitocin for Second Trimester Abortion
- Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded Trial
- A Phase I Study to Determine the Effect of Mifepristone on the Pharmacokinetics of Fluvastatin in Healthy Volunteers
- Treatment of Schizoaffective Disorder Using Mifepristone
- Glucocorticoid Receptor Antagonism in Subclinical Cushings
- Mifepristone for Treatment of Uterine Fibroids
- A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers
- A Controlled Trial of Mifepristone in Gulf War Veterans With Chronic Multisymptom Illness
- Comparing Two Regimens for Medical Abortion: Mifepristone+Misoprostol Versus Misoprostol Alone
- Medical Abortion for Emergency Contraception Failure
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
- Second Trimester Labor Induction
- The Effect of Mifepristone on Uterine Fibroids and Breast Tissue
- A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
- A Clinical Trial for Post Traumatic Stress Disorder
- Mifepristone for Patients With Endometrial Cancer and LGESS
- Study of 400mcg Versus 800mcg Buccal Misoprostol Following Mifepristone 200mg for Abortion up to 63 Days Gestation
- MiMi: A Randomized Trial of Mifepristone and Misoprostol for Treatment of Early Pregnancy Failure
- Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
- A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain
- Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
- Cervical Rippening With Antiprogesterone in Midtrimester Abortions
- A Randomized Trial of Buccal Compared to Oral Misoprostol Following Mifepristone for Medical Abortion up to 63 Days LMP
- Acceptability and Feasibility of Medical Abortion Using Mifepristone and Buccal Misoprostol
- Mifepristone Versus Laminaria for Cervical Ripening in Midtrimester Induction
- Mifepristone and Mid-Trimester Termination of Pregnancy
- RU-486 in the Treatment of Bipolar Depression
- Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects
- Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days Gestation
- Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation
- Mifepristone Treatment for Patients With Non-psychotic Major Depressive Disorder Receiving Bilateral ECT
- Mifepristone at Same Time Multicenter Study
- Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients
- A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas
- A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
- Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone
- Expectant Versus Immediate Medical Management for the Evacuation of the no Evolutionary Pregnancies Before 13 GW
- Mifepristone in Refractory Depression
- Mifepristone and Misoprostol for Fetal Demise
- An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression
- A Randomized Trial of Two Regimens of Misoprostol for Second Trimester Termination for Intrauterine Fetal Death
- Mifepristone (RU-486) in Androgen Independent Prostate Cancer
- Trial of Mifepristone for Fibroids
- A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression
- Comparing Methotrexate Followed by Misoprostol to Misoprostol Alone for Early Abortion
- An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
- A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression
- Mifepristone as Adjunctive Therapy in Alzheimer's Disease
- Anti-HIV Activity and Safety of 3 Different Doses of Mifepristone in HIV Infected People
- Brain Receptor Function in Post-Traumatic Stress Disorder
- Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist
- Clinical Trial of Mifepristone for Bipolar Depression
- New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Clinical trials list
click for details